Longitudinal assessments involving 758 T2DM patients further revealed a correlation between monocyte chemotactic protein-1 levels (MCP-1) and the progression of DR (Ninomiya et al., 2015). The gene discussed is CCL2; the disease is type 2 diabetes mellitus.